Sapporo Clinical Laboratory Inc.

TSE:9776 Stock Report

Market Cap: JP¥3.0b

Sapporo Clinical Laboratory Past Earnings Performance

Past criteria checks 1/6

Sapporo Clinical Laboratory's earnings have been declining at an average annual rate of -4.9%, while the Consumer Retailing industry saw earnings growing at 9.3% annually. Revenues have been growing at an average rate of 3.5% per year. Sapporo Clinical Laboratory's return on equity is 3.3%, and it has net margins of 1.9%.

Key information

-4.9%

Earnings growth rate

-4.2%

EPS growth rate

Consumer Retailing Industry Growth7.8%
Revenue growth rate3.5%
Return on equity3.3%
Net Margin1.9%
Next Earnings Update12 Feb 2025

Recent past performance updates

Recent updates

Be Wary Of Sapporo Clinical Laboratory (TSE:9776) And Its Returns On Capital

Aug 06
Be Wary Of Sapporo Clinical Laboratory (TSE:9776) And Its Returns On Capital

Sapporo Clinical Laboratory's (TSE:9776) Weak Earnings May Only Reveal A Part Of The Whole Picture

May 21
Sapporo Clinical Laboratory's (TSE:9776) Weak Earnings May Only Reveal A Part Of The Whole Picture

Sapporo Clinical Laboratory (TYO:9776) Is Reinvesting At Lower Rates Of Return

Mar 29
Sapporo Clinical Laboratory (TYO:9776) Is Reinvesting At Lower Rates Of Return

Sapporo Clinical Laboratory (TYO:9776) Shareholders Have Enjoyed A 47% Share Price Gain

Feb 11
Sapporo Clinical Laboratory (TYO:9776) Shareholders Have Enjoyed A 47% Share Price Gain

Should You Use Sapporo Clinical Laboratory's (TYO:9776) Statutory Earnings To Analyse It?

Dec 24
Should You Use Sapporo Clinical Laboratory's (TYO:9776) Statutory Earnings To Analyse It?

Revenue & Expenses Breakdown

How Sapporo Clinical Laboratory makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSE:9776 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2419,8163764,5910
30 Jun 2419,7594314,5790
31 Mar 2419,6823804,5600
31 Dec 2319,7293864,5190
30 Sep 2320,0255364,4970
30 Jun 2320,1494954,4710
31 Mar 2320,1275684,4870
31 Dec 2220,0748744,4450
30 Sep 2219,5078434,3020
30 Jun 2219,3711,0134,1760
31 Mar 2219,1091,0424,0800
31 Dec 2118,8029714,0990
30 Sep 2118,7041,0254,0620
30 Jun 2118,0669013,9960
31 Mar 2117,5027933,9110
31 Dec 2017,2995163,8970
30 Sep 2017,1854273,9170
30 Jun 2017,3073483,9420
31 Mar 2017,6595283,9060
31 Dec 1917,5326403,9140
30 Sep 1917,4706433,8490
30 Jun 1917,2146373,7890
31 Mar 1917,0655233,7850
31 Dec 1817,1585483,7520
30 Sep 1817,1765453,7400
30 Jun 1817,3575583,7600
31 Mar 1817,4596853,7310
31 Dec 1717,3996553,7240
30 Sep 1717,3386203,7100
30 Jun 1717,1966253,6870
31 Mar 1717,0555133,6950
31 Dec 1617,2385094,1970
30 Sep 1617,3665094,2070
30 Jun 1617,4634994,1880
31 Mar 1617,5285904,1580
31 Dec 1517,6406594,1250
30 Sep 1517,4626584,1280
30 Jun 1517,3436914,1250
31 Mar 1517,1665734,1330
31 Dec 1416,7284244,1210
30 Sep 1416,6824573,9870
30 Jun 1416,5854003,9020
31 Mar 1416,5494933,8130
31 Dec 1316,5636223,7170

Quality Earnings: 9776 has high quality earnings.

Growing Profit Margin: 9776's current net profit margins (1.9%) are lower than last year (2.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 9776's earnings have declined by 4.9% per year over the past 5 years.

Accelerating Growth: 9776's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 9776 had negative earnings growth (-29.9%) over the past year, making it difficult to compare to the Consumer Retailing industry average (10.5%).


Return on Equity

High ROE: 9776's Return on Equity (3.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 04:10
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sapporo Clinical Laboratory Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Masao YoshidaIchiyoshi Research Institute Inc.